The Food is Medicine National Network of Excellence aims to improve healthcare by integrating nutritional interventions into treatment models. It addresses issues like poor diets and food insecurity, which lead to health disparities and high costs. The initiative seeks to enhance patient care and promote health equity nationwide. (Link)
Abridge, a leading generative AI platform focused on clinical conversations, aims to enhance its AI capabilities and support commercial expansion. The platform is implemented in over 100 health systems across the United States, improving clinical documentation efficiency by generating comprehensive, billable notes at the point of care and streamlining revenue cycle workflows. (Link)
Qualified Health's platform offers healthcare organizations the tools to safely implement and scale AI solutions, addressing governance, security, and trust concerns. Qualified Health's platform capabilities include enforceable governance, healthcare agent creation, and post-deployment monitoring. The company aims to help healthcare systems overcome challenges in scaling AI, such as potential risks of AI hallucinations, PHI leaks, and biased outputs. (Link)
Lizzy Care's platform combines technology and companionship to support individuals with dementia. The seed funding will enhance the platform by integrating predictive analytics and real-time care coordination, ensuring proactive care. Lizzy Care aims to improve patient and caregiver quality of life while expanding services and developing technology for better care management. (Link)
Newleos Therapeutics is advancing oral small molecule drugs targeting neuropsychiatric disorders, including anxiety and cognitive impairment. Its lead program, NTX-1955, is designed to treat anxiety by specifically modulating GABAergic transmission in the anxiety brain circuit. The company plans to conduct proof-of-concept clinical trials for this and other programs. (Link)
Avandra is creating the world's largest federated network for de-identified medical imaging data to enhance research and patient care by organizing medical images. The platform aims to solve access challenges, providing a marketplace for biopharma and researchers to drive innovation and improve patient outcomes through better access to valuable imaging data. (Link)
Endovascular Engineering, Inc. (E2) is advancing its Hēlo™ PE Thrombectomy System for treating venous thromboembolism, particularly pulmonary embolism. The system is currently in pivotal trials, aiming to establish it as the gold standard in mechanical thrombectomy. E2 also appointed Dr. Ruben Osnabrugge and Brian R. Smith to its board. (Link)
Nexmedis aims to revolutionize healthcare in Indonesia by enhancing clinical services and patient outcomes. Founded in 2023 by Yehuda Dani Utomo, Matilda Narulita, and Dr. Almer Deta Tarandha, the company has served over 400 facilities and is developing AI tools, including a transcription tool to streamline operations. (Link)
Cleveland Diagnostics' IsoPSA test is a next-generation blood assay for prostate cancer risk, superior to traditional PSA tests. It reduces unnecessary biopsies by distinguishing high-grade from low-grade cancers. IsoPSA measures PSA protein changes, offering precise cancer detection. Cleveland Diagnostics is expanding IsoPSA's reach and developing tests for other cancers (Link)
Lynx, a healthcare payments fintech, secured Series A funding to scale its API-based platform. The platform enables companies to create healthcare-focused products like CDH accounts and custom OTC storefronts. Led by CEO Matthew Renfro, Lynx's platform supports payment types including CDH, ICHRA, and Medicare Advantage supplemental benefits, allowing the embedding of financial accounts into user experiences. Victor Lanio will join Lynx’s board. (Link)
From March 3-6, 2025, health and technology experts will gather to discuss challenges and solutions in the healthcare industry. This event will host over 1,000 healthcare companies and startups showcasing innovative products. Key topics include health equity, AI, data governance, and digital transformation. Attendees can expect networking events and educational sessions (Link)
The Health 2.0 Conference is a leading global event focused on healthcare innovation, digital health, and emerging technologies. Taking place from March 4–6, 2025, in Las Vegas, Nevada, it brings together healthcare professionals, entrepreneurs, and technology experts to discuss advancements in AI, telemedicine, patient-centric care, and health tech startups. The conference features keynote sessions, panel discussions, networking opportunities, and showcases of groundbreaking healthcare solutions aimed at transforming the industry. (Link)
The 11th annual summit on March 13-14, 2025, convenes Utah's life science leaders and investors to discuss funding and commercialization. Presented by BioUtah and the University of Utah Technology Licensing Office, the summit follows a record-breaking year that saw over 450 attendees. (Link)